Factors Influencing Drug Absorption: Drug Dissolution

Drug absorption from tablets or capsules occurs through three sequential steps. First, disintegration breaks the solid drug into smaller particles. Next, dissolution causes these particles to dissolve in gastrointestinal fluids. Finally, the dissolved drug permeates the intestinal membrane, entering the bloodstream for systemic circulation.

The BCS categorizes drugs into four classes based on solubility and permeability. Class I drugs have high solubility and permeability, enabling good oral absorption. Class II drugs have low solubility but high permeability. Class III drugs have high solubility but low permeability. Class IV drugs have both low solubility and permeability, resulting in poor absorption.

The drug's physicochemical properties determine the rate-limiting step. For lipophilic or poorly aqueous soluble drugs, dissolution is rate-limiting. For hydrophilic drugs, permeation through lipid membranes is rate-limiting. Extended-release formulations intentionally control dissolution to achieve prolonged drug release and optimize bioavailability.

Dissolution dynamics correlate more strongly with overall drug absorption and bioavailability than absolute solubility alone. Drugs with low intrinsic solubility can still achieve sufficient absorption if they dissolve rapidly and have a small therapeutic dose, allowing adequate absorption within the gastrointestinal transit period.

Solubility challenges substantially impact dissolution rate, particularly for compounds with aqueous solubility below 1-2 mg/ml within the gastrointestinal pH range of 2 to 8. Drugs with such low solubility face significant absorption limitations unless they possess rapid dissolution kinetics or small therapeutic doses to ensure adequate bioavailability.

Disintegration is a prerequisite for dissolution. It breaks solid dosage forms into minute particles, increasing surface area available for dissolution. These granulated particles then solubilize in gastrointestinal fluids, enabling the dissolved drug to subsequently permeate the intestinal membrane for absorption into systemic circulation.

Lipophilic drugs typically have poor aqueous solubility, making dissolution the rate-limiting step in their absorption process. Hydrophilic drugs, conversely, dissolve readily but struggle to permeate lipid membranes, making permeation rate-limiting. These differences necessitate distinct pharmaceutical strategies for optimizing drug bioavailability and therapeutic efficacy.